This is my fourth year attending the American Society of Hematology (ASH) meeting virtually. While I miss seeing my myeloma support group leader faMMily in person, there are some nice perks to...
Jill Zitzewitz, PhD
Jill Zitzewitz, PhD is an associate professor in academic medicine where she has spent her career studying protein misfolding diseases. Since being diagnosed with MM in 2017, Jill now uses her experience to provide patient perspective to future doctors and scientists. Jill’s four children were teenagers when she was diagnosed, and she’s grateful that current myeloma therapies have allowed her to continue working and to be present for her children. In 2020, Jill became the leader for the Central MA Multiple Myeloma Support Group. For her 4th ASH experience, Jill plans to use her background in science and education to help other patients understand the impact of new and novel therapies for treating MM.
Follow Jill on X: @JillZitzewitz
Support Group Website: Central MA Multiple Myeloma Support Group
Many Unique Data Points on the Myeloma Treatment Landscape
Friday is Satellite Symposia Day! It’s the day before the official meeting starts, when industry partners sponsor continuing medical education sessions for community treating physicians. I attended...
Finding a Healthy New Rhythm
I have been a multiple myeloma patient for nearly eight years, and during this time there have been so many changes in my life. As a patient, I’ve now been on my second line of therapy twice as long...